P2 Capital Partners’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,452
Closed -$1.52M – 15
2026
Q2
$1.52M Sell
18,452
-127,277
-87% -$9M 0.62% 12
2026
Q1
$9.26M Sell
145,729
-348,173
-70% -$22.5M 4.41% 9
2025
Q4
$30.4M Hold
493,902
– – 7.79% 6
2025
Q3
$25.9M Sell
493,902
-20,000
-4% -$1.01M 4.97% 9
2025
Q2
$23.1M Sell
513,902
-39,000
-7% -$1.61M 4.43% 11
2025
Q1
$21.7M Buy
552,902
+42,100
+8% +$1.89M 4.22% 9
2024
Q4
$23.7M Sell
510,802
-539,198
-51% -$27.6M 4.02% 9
2024
Q3
$55.2M Buy
1,050,000
+100,000
+11% +$4.96M 6.3% 8
2024
Q2
$52.1M Buy
950,000
+150,000
+19% +$8.55M 5.71% 8
2024
Q1
$44.8M Sell
800,000
-50,000
-6% -$2.6M 5.29% 9
2023
Q4
$44M Hold
850,000
– – 4.84% 10
2023
Q3
$44.9M Hold
850,000
– – 5.88% 7
2023
Q2
$43.7M Hold
850,000
– – 5.09% 10
2023
Q1
$37M Hold
850,000
– – 4.75% 9
2022
Q4
$47.2M Hold
850,000
– – 6.24% 6
2022
Q3
$43.2M Sell
850,000
-100,000
-11% -$5.94M 5.33% 6
2022
Q2
$59.3M Buy
950,000
+298,417
+46% +$21.1M 6.72% 3
2022
Q1
$53.3M Hold
651,583
– – 5.04% 9
2021
Q4
$57M Buy
+651,583
New +$54.3M 4.44% 12

Other funds holding LIVN

P2 Capital Partners's LIVN Position: Q3 2026 in Review

P2 Capital Partners sold out of LivaNova (LIVN) in Q3 2026, closing a stake of 18,452 shares — an estimated $1.52M sold.

P2 Capital Partners first reported a position in LIVN in Q4 2021 and held it in 19 quarters. The position peaked at $59.3M in Q2 2022. 322 funds tracked by Wall St. Rank hold LIVN as of Q3 2026.

  • P2 Capital Partners reported no remaining LivaNova position as of Q3 2026 after selling out during the quarter.
  • P2 Capital Partners sold 18,452 LivaNova shares in Q3 2026, an estimated $1.52M.
  • P2 Capital Partners first reported a position in LivaNova in Q4 2021 and held it in 19 quarters.
  • P2 Capital Partners's LivaNova position peaked at $59.3M in Q2 2022.
  • 322 funds tracked by Wall St. Rank held LivaNova as of Q3 2026.

Based on P2 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.